BRPI0216033B8 - "Peptide-based immunization therapy for the treatment of arteriosclerosis" - Google Patents
"Peptide-based immunization therapy for the treatment of arteriosclerosis"Info
- Publication number
- BRPI0216033B8 BRPI0216033B8 BRPI0216033A BR0216033A BRPI0216033B8 BR PI0216033 B8 BRPI0216033 B8 BR PI0216033B8 BR PI0216033 A BRPI0216033 A BR PI0216033A BR 0216033 A BR0216033 A BR 0216033A BR PI0216033 B8 BRPI0216033 B8 BR PI0216033B8
- Authority
- BR
- Brazil
- Prior art keywords
- peptide
- treatment
- arteriosclerosis
- immunization therapy
- cardiovascular diseases
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
terapia de imunizaçao a base de peptídio para tratamento de arteriosclerose e desenvolvimento de ensaio a base de peptídio para determinaçao de respostas imunes contra lipoproteina oxidada de baixa densidade. a presente invenção se refere a fragmentos de apoliproteina b, em particular a peptídios definidos dos mesmos, para imunização ou tratamento terapêutico de mamíferos, incluindo seres humanos, contra doenças cardiovasculares isquêmicas, assim como para diagnosticar a presença ou ausência de anticorpos correlacionados ao aumento ou redução de risco de desenvolvimento de doenças cardiovasculares isquêmicas, usando um ou mais dos peptídios em um ensaio elisa (enzyme linked immuno sorbent assay).peptide-based immunization therapy for the treatment of arteriosclerosis and development of a peptide-based assay for the determination of immune responses against oxidized low-density lipoprotein. the present invention relates to fragments of apoliprotein b, in particular to defined peptides thereof, for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases, as well as for diagnosing the presence or absence of antibodies correlated with the increase or reducing the risk of developing ischemic cardiovascular diseases, using one or more of the peptides in an elisa assay (enzyme linked immunosorbent assay).
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101232-7 | 2001-04-05 | ||
| SE0101232A SE0101232D0 (en) | 2001-04-05 | 2001-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density liprotein |
| SE0103754A SE0103754L (en) | 2001-04-05 | 2001-11-09 | Peptides from apolipoprotein B, use thereof immunization, method of diagnosis or therapeutic treatment of ischemic cardiovascular diseases, and pharmaceutical composition and vaccine containing such peptide |
| SE0103754-8 | 2001-11-09 | ||
| BRPI0208685 | 2002-04-05 | ||
| PCT/SE2002/000679 WO2002080954A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0216033B1 BRPI0216033B1 (en) | 2018-01-02 |
| BRPI0216033B8 true BRPI0216033B8 (en) | 2021-05-25 |
Family
ID=62529384
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0216033A BRPI0216033B8 (en) | 2001-04-05 | 2002-04-05 | "Peptide-based immunization therapy for the treatment of arteriosclerosis" |
| BRPI0216049A BRPI0216049B8 (en) | 2001-04-05 | 2002-04-05 | "Peptide-based immunization therapy for the treatment of arteriosclerosis" |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0216049A BRPI0216049B8 (en) | 2001-04-05 | 2002-04-05 | "Peptide-based immunization therapy for the treatment of arteriosclerosis" |
Country Status (1)
| Country | Link |
|---|---|
| BR (2) | BRPI0216033B8 (en) |
-
2002
- 2002-04-05 BR BRPI0216033A patent/BRPI0216033B8/en not_active IP Right Cessation
- 2002-04-05 BR BRPI0216049A patent/BRPI0216049B8/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0216049B1 (en) | 2018-01-02 |
| BRPI0216049B8 (en) | 2021-05-25 |
| BRPI0216033B1 (en) | 2018-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0208685A (en) | Peptide-based immunization therapy for atherosclerosis treatment and development of peptide-based assay for determination of immune responses against low-density oxidized lipoprotein | |
| ECSP024409A (en) | DOUBLE SPECIFICITY ANTIBODIES AND METHODS FOR THE ELABORATION AND USE OF THE SAME | |
| AT500379B1 (en) | TAU PROTEINS | |
| CY1117387T1 (en) | Monoclonal N-11 Dispersed β-Amyloid Antibodies, COMPOSITIONS, METHODS AND USES | |
| HUP0400313A2 (en) | A novel engineered superantigen for human therapy | |
| BR0207283A (en) | Reduced immunogenicity modified anti-egfr antibodies | |
| HUP0301877A2 (en) | Aromatase inhibitors and monoclonal anti-her2 antibodies as antitumors agents | |
| Tian et al. | Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease | |
| DK0858504T3 (en) | Diagnostic remedies and treatments for periodontal diseases | |
| Zhang et al. | Immunization with heat shock protein A and γ-glutamyl transpeptidase induces reduction on the Helicobacter pylori colonization in mice | |
| EA200400134A1 (en) | THERAPEUTIC AGENT | |
| SE0302312D0 (en) | Peptide-based passive immunization therapy for the treatment of atherosclerosis | |
| BRPI0216033B8 (en) | "Peptide-based immunization therapy for the treatment of arteriosclerosis" | |
| BR0208124A (en) | Antibodies for the prevention and treatment of Escherichia coli binding and elimination diseases (aeec) | |
| ATE338819T1 (en) | ANTIGENIC PROTEIN FROM MALASSEZIA | |
| BRPI0414688A (en) | anti-il-2 receptor respiratory disease treatment | |
| KR100310413B1 (en) | Human natural lgM antibody | |
| Kim et al. | Secretome analysis of host cells infected with Toxoplasma gondii after treatment of human epidermal growth factor receptor 2/4 inhibitors | |
| Kambayashi et al. | Preparation and characterization of a polyclonal antibody against brominated protein | |
| SE0104354D0 (en) | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based ELISA for determination of immune responses against oxidized low-density lipoprotein | |
| Loureiro et al. | Properties of cryptic epitopes and their corresponding antibodies as indicated by the study of human and ovine growth hormones | |
| Levy et al. | 12 Obstructive sleep apnea in children with chronic rhinitis | |
| Harris et al. | 11 A fluorescence enzyme immunoassay for allergen-specific IgG4 | |
| WO2004035003A3 (en) | Therapeutic adjuvant | |
| BR9908374A (en) | Composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A(S) 7A ANUIDADE(S). |
|
| B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2108 DE 31/05/2011. |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: CARDIOVAX, LLC (US) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/04/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 05/04/2022 |